Skip to main content

Cookies

This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie policy for more information on the use of cookies on this website.

Top
  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
  • Products
    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Sterilization Services
    • Microplate Coding Services
  • Services
    • GENEWIZ Multiomics & Synthesis Solutions
    • Better Storage Management
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Services & Support
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Utility Navigation

  • Order Login
  • GENEWIZ
  • B Medical
  • Barkey
  • Limfinity Sample Management System
  • Distributor Login
  • Portals
Home

Utility Navigation

  • Order Login
  • GENEWIZ
  • B Medical
  • Barkey
  • Limfinity Sample Management System
  • Distributor Login
  • Portals

Main Navigation

  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
    Resources Center

    Learn about sample management best practices, gain advice from industry leaders, gain access to global regulatory and logistics guidelines and find simple support tools that can help you make better sample management decisions.

    Resources Center
  • Products
    Azenta Sample Pack and Catalog
    Sample Tube Pack Request

    Improve sample tracking, ensure sample integrity and drive process efficiency with Azenta Sample Storage Tubes. Explore the range, and select the best tube for your workflow.

    Low DNA Binding Microplates
    Low Binding Microplates

    Ultra low DNA binding microplates made from PP, fit for Next Generation Sequencing (NGS) and other sensitive applications with ultra-low DNA input. Off the shelf options. Custom solutions on request.

    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Sterilization Services
    • Microplate Coding Services
  • Services
    Clinical Trial Management
    Clinical Trial Services & Support

    Life science organizations must collect and manage large numbers of research samples to bring a new therapeutic or diagnostic to market. This is a complex process.

    Sample Preparation & Lab Analytical Services
    GENEWIZ Multiomics & Synthesis Solutions

    Comprehensive genomics sequencing, synthesis and multiomics solutions for research, discovery and clinical phase customers.

    • GENEWIZ Multiomics & Synthesis Solutions
    • Better Storage Management
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Services & Support
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    disaster recovery
    How Safe Are Your Samples?

    Plastic storage tubes are used in laboratories worldwide to store biological and chemical samples.

    Product Support Plans
    Product Support Plans

    Azenta  Life Sciences' world class service team is committed to ensuring you meet your business objectives by providing a flexible portfolio of service products designed to optimize up-time and productivity.

    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    Putting a Sample Kit in an envelope
    Quality Assurance Certifications

    Azenta Life Sciences has established, documented, implemented and currently maintains a quality management system that fulfills the needs of customers.

    About Azenta Life Sciences
    About Azenta Life Sciences

    We are Azenta Life Sciences. We provide unrivaled sample exploration and management solutions to help our customers accelerate discovery, development and delivery.

    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Board of Directors

  • Frank E. Casal Director

    Committees:

    • Audit (Chair)
    • Finance

    Attributes and skills:

    • Global business experience
    • Financial management and accounting
    • Audit
    • Risk management and investment stewardship experience
    • Financing transactions
    • Mergers & acquisitions / integrations
    • Experience in highly regulated industries
    • Leadership and talent development

    Expertise provided to the Board:

    Following forty years at KPMG in various roles, including as Vice Chair of Audit, Frank E. Casal brings best-in-class knowledge of financial reporting, accounting and audit, drawing on his experience providing supervisory responsibilities to large, global Fortune 500 companies. To the Azenta Board, he brings significant expertise in transforming businesses through mergers and acquisitions, financing transactions and other strategic priorities, including Azenta’s split from Brooks Automation. Having led a division of almost 9,000 professionals, he has proven leadership and management experience. He provides a unique perspective to the Board as it manages talent and human capital to support efforts to grow the Company and generate shareholder value.

  • Robyn C. Davis Director

    Committees:

    • Finance (Chair)
    • Human Resources and Compensation

    Attributes and skills:

    • Leadership experience in life sciences and healthcare companies
    • Risk management and investment stewardship experience
    • Operational experience in capital-intensive, innovation-focused industries
    • Growth strategies and market expansion
    • Mergers & acquisitions / integrations
    • Leadership and talent development

    Expertise provided to the Board:

    As a Managing Director at an early-stage angel investment group focused on medical devices, life sciences and pharmaceutical companies, Robyn C. Davis brings a valuable investor perspective geared towards maximizing value for shareholders. She also possesses strong financial acumen, particularly as it relates to operational matters, and experience supporting companies as they scale and grow, both organically and through mergers and acquisitions, having successfully exited certain portfolio companies and sat on the Board of CRA Health during its acquisition by Volpara. She brought her experience in operations, growth and life sciences to the Board as Azenta transitioned from Brooks Automation into a standalone global market leader. She has more than three decades of independent C-suite consulting experience with both corporate and non-governmental organizations helping to lead value-creation strategies in growth, cost reduction, leadership and talent development.

  • Joseph R. Martin Chairman of the Board

    Committees:

    • Executive (Chair)
    • Nominating and Governance

    Attributes and skills:

    • Leadership experience in life sciences and healthcare companies
    • Public-company director experience
    • Global business experience
    • Operational experience in capital-intensive, innovation-focused industries
    • Financial management and accounting
    • Mergers & acquisitions / integrations
    • Experience in highly regulated industries

    Expertise provided to the Board:

    Joseph R. Martin serves as Chairman of the Board and is a seasoned executive with extensive strategic and operational experience in multibillion-dollar manufacturing corporations, particularly in technological and medical-technology industries. He successfully led the Board as Chairman during the Company’s transition from Brooks Automation to Azenta Life Sciences, bringing to bear his significant experience in life sciences and strategic transformations. In addition, he brings extensive experience in accounting and financial reporting, mergers and acquisitions, taxation, risk management, compliance and investor relations to the Azenta Board, providing insight and a critical perspective across all areas of the business as it generates value for shareholders.

  • Erica J. McLaughlin Director

    Committees:

    • ESG (Chair)
    • Audit

    Attributes and skills:

    • Global business experience
    • Financial management and accounting
    • Audit
    • Growth strategies and market expansion
    • ESG
    • Mergers & acquisitions / integrations
    • Leadership and talent development

    Expertise provided to the Board:

    As a results-driven Executive Vice President, CFO and Head of Corporate Strategy of a public company, Erica J. McLaughlin brings extensive international business experience and expertise in financial areas and strategy and a strong background in accounting and audit. She also has significant experience in mergers, acquisitions and integrations, as well as industrial knowledge of life sciences, having served on Azenta’s Board during its Company’s transition from Brooks Automation. With proven general management and leadership experience at global organizations, she has her finger on the pulse of best-practice corporate governance and sustainable growth strategies. Further, her experience both as the Inaugural Chairperson of Cabot’s Diversity and Inclusion Steering Committee and as Co-Chair of the Governance pillar at Cabot’s ESG executive management structure, means that she brings valuable insights relating to ESG, DEI and other matters top-of-mind for leadership.

  • Tina S. Nova Director

    Committees:

    • Audit

    Attributes and skills:

    • Leadership experience in life sciences and healthcare companies
    • Global business experience
    • Growth strategies and market expansion
    • Public-company director experience
    • Mergers & acquisitions / integrations
    • Operational experience in capital-intensive, innovation-focused industries
    • Experience in highly regulated industries

    Expertise provided to the Board:

    Tina S. Nova is an industry veteran in life sciences, with deep experience in building and leading businesses in the industry, providing deep insights into best-in-class operations, sales and marketing efforts. She also brings significant experience in mergers, acquisitions and integration, having overseen the sale of several companies as both an executive and director that created value for shareholders. She also provides relevant life sciences executive leadership experience, having held Chief Executive roles at Decipher Biosciences, until its $600 million sale to Veracyte in 2021, Molecular Stethoscope and Genoptix, which she co-founded and oversaw its $470 million sale to Novartis AG in 2011.

  • Dr. Krishna G. Palepu Director

    Committees:

    • Nominating and Governance (Chair)
    • Executive
    • Finance

    Attributes and skills:

    • Public-company director experience
    • Life sciences experience
    • Global business experience
    • Growth strategies and market expansion
    • Mergers & acquisitions/integrations
    • Corporate governance
    • Leadership and talent development

    Expertise provided to the Board:

    Krishna G. Palepu provides the Board with his deep strategic, marketing, financial and technology insights, arising out of service as a professor and a leader at an internationally renowned business school. He brings extensive knowledge of globalization, emerging markets, global strategy and life sciences thanks to his research at Harvard and consulting experience with leading companies world-wide. He brings life sciences industry experience from his board work in pharmaceutical, healthcare, and Gene and Cell therapy manufacturing spaces, and the role he played in facilitating the Company’s transition from Brooks Automation to Azenta Life Sciences. He also provides a unique perspective to the Board as it develops its growth and market expansion strategy and delivers shareholder value. He has industry-leading experience in corporate governance and consults for a wide range of companies worldwide, affording the Azenta Board the benefit of his global and culturally diverse perspective and his experience in strategy, finance and leadership development.

  • Dorothy E. Puhy Director

    Committees:

    • Audit

    Attributes and skills:

    • Public-company director experience
    • Executive leadership experience at healthcare and life sciences companies
    • Growth strategies and market expansion
    • Operational experience in capital-intensive, innovation-focused industries
    • Experience in highly regulated industries

    Expertise provided to the Board:

    As a leading executive at a world-renowned medical research institute, Dorothy E. Puhy brings deep expertise in life sciences, enabling her to assess both organic and inorganic growth opportunities that will generate value for shareholders. Her extensive experience in management and board-level positions at major health institutions, including not-for-profit organizations, private organizations and the Harvard School of Public Health, where she served as a longstanding member of the adjunct faculty, provides the Board with deep insights into cutting-edge innovation and R&D, as well as organic and inorganic growth opportunities that drive value for shareholders.

  • Michael Rosenblatt, M.D. Director

    Committees:

    • ESG
    • Human Resources and Compensation

    Attributes and skills:

    • Leadership experience in life sciences and healthcare companies
    • Global business experience
    • Risk management and investment stewardship
    • Growth strategies and market expansion
    • Experience in highly regulated industries

    Expertise provided to the Board:

    Michael Rosenblatt, MD has deep leadership and executive experience in the biotechnology industry, including as the chief medical officer of a major pharmaceutical company and at a substantial life sciences investment firm. He also has deep board-level and management team experience as a founding scientist, scientific advisory Board member, director of more than a dozen biopharmaceutical companies and Board member during the Company’s transition from Brooks Automation to Azenta Life Sciences. Further, thanks to his academic leadership experience as a dean and professor at prestigious medical schools and as a leader in the biotech industry, including as a winner of the Fuller Albright Award, he has extensive expertise in drug discovery and medical research, bringing unique industry insights to the Azenta Board, particularly as it relates to the customer perspective, research and development, as well as opportunities in the marketplace.

  • Dr. Stephen Schwartz President & Chief Executive Officer

    Committees:

    • Executive
    • Environmental, Social & Governance

    Attributes and skills:

    • Current CEO of public company
    • Leadership experience in life sciences and healthcare companies
    • Public-company director experience
    • Global business experience
    • Operational experience in capital-intensive, innovation-focused industries
    • Growth strategies and market expansion
    • Mergers & acquisitions / integrations
    • Experience in highly regulated industries

    Expertise provided to the Board:

    Stephen S. Schwartz serves as Azenta’s President and Chief Executive Officer, bringing his insights into the day-to-day business and operations. Since joining the Company in 2010, he has successfully managed its transition from Brooks Automation into Azenta, transforming the Company into a global market leader, quadrupling revenues and meaningfully outgrowing the life-sciences market over the last five years. He has demonstrated expertise across many facets of the business, serving in both operational and executive leadership positions. He has a proven track record in the successful execution of mergers, acquisitions and integrations, having successfully integrated 10 acquisitions over the past decade, generating significant value for shareholders.

  • Ellen M. Zane Director

    Committees:

    • Human Resources and Compensation (Chair)
    • Executive
    • Nominating and Governance

    Attributes and skills:

    • Leadership experience in life sciences and healthcare companies
    • Public-company director experience
    • Global business experience
    • Growth strategies and market expansion
    • Operational experience in capital-intensive, innovation-focused industries
    • Financial management and accounting

    Expertise provided to the Board:

    Ellen M. Zane is an industry leader and seasoned executive in the healthcare industry, with prodigious experience as a public-company Director and as the chief executive officer of a large academic medical center. She has a strong record of driving growth and enhances the Board’s collective expertise in growth strategies, having led the development of one the largest physician networks in the U.S and serving on the Board during the Company’s transition from Brooks Automation to Azenta Life Sciences. She also brings strong operational experience, having led the turnaround of Tufts Medical Center and Tufts Children’s Hospital in Boston, returning the organization to financial stability. As part of that turnaround, she also strengthened the organization’s academic relationships with Tufts University School of Medicine to deliver high-quality, cost-efficient patient-centered care. As such, she also brings to the Azenta Board experience collaborating with academia and technical experts to better understand the risks and opportunities in the healthcare and life sciences industry.

Home
Facebook twitter youtube linkedin
Copyright © 2023 Azenta US, Inc.

Footer menu

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Terms of Use
  • Careers
  • Subscribe